MORRIS PLAINS, N.J., Aug. 7, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will present at 2012 Wedbush PacGrow Life Sciences Management Access Conference on Tuesday, August 14th at 1:55 pm Eastern time at Le Parker Meridien Hotel in New York City. The presentation, which will provide a corporate overview, can be downloaded simultaneously at www.immunomedics.com/1aboutus/present.pdf.
